Clinical trials of muse cells

Research output: Chapter in Book/Report/Conference proceedingChapter

7 Citations (Scopus)

Abstract

Among many kinds of somatic stem cells, hematopoietic stem cells are the cells that have been successfully applied to treating leukemia patients as forms of bone marrow and cord blood transplantation. Mesenchymal stem cells, collectable from several sources including the bone marrow and adipose tissue, are also widely applied to clinical trials for their easy accessibility and low risks of tumorigenesis, while their outcomes were shown to be not clinically relevant in several target diseases. The most important issue for the stem cells is whether the cells are safe and effective for curing diseases. In this chapter, the outline of the clinical trial in Muse cells is discussed.

Original languageEnglish
Title of host publicationAdvances in Experimental Medicine and Biology
PublisherSpringer New York LLC
Pages305-307
Number of pages3
DOIs
Publication statusPublished - 2018

Publication series

NameAdvances in Experimental Medicine and Biology
Volume1103
ISSN (Print)0065-2598
ISSN (Electronic)2214-8019

Keywords

  • Allogenic transplantation
  • Autologous transplantation
  • Donor
  • ES cells
  • Intravenous injection
  • Mesenchymal stem cells
  • Non-tumorigenicity
  • iPS cells

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Fingerprint

Dive into the research topics of 'Clinical trials of muse cells'. Together they form a unique fingerprint.

Cite this